title: [The beneficial action of Navoban during antineoplastic chemotherapy].
authors.forename: A M
authors.initials: AM
authors.lastname: Garin
authors.forename: D Z
authors.initials: DZ
authors.lastname: Kupchan
authors.forename: A G
authors.initials: AG
authors.lastname: Kirsanov
authors.forename: N M
authors.initials: NM
authors.lastname: Ivanova
authors.forename: V V
authors.initials: VV
authors.lastname: Il'iashenko
mesh_terms: D000328:Adult; D000932:Antiemetics / Q000009:adverse effects / Q000627:therapeutic use*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000009:adverse effects*; D001761:Bleomycin / Q000008:administration & dosage / Q000009:adverse effects; D002648:Child; D002945:Cisplatin / Q000008:administration & dosage / Q000009:adverse effects; D003520:Cyclophosphamide / Q000008:administration & dosage / Q000009:adverse effects; D003609:Dactinomycin / Q000008:administration & dosage / Q000009:adverse effects; D004341:Drug Evaluation; D006801:Humans; D007211:Indoles / Q000009:adverse effects / Q000627:therapeutic use*; D009959:Oropharyngeal Neoplasms / Q000150:complications / Q000188:drug therapy; D012074:Remission Induction; D000077526:Tropisetron; D014747:Vinblastine / Q000008:administration & dosage / Q000009:adverse effects; D014839:Vomiting / Q000139:chemically induced / Q000188:drug therapy
chemical_list: D000932:Antiemetics; D007211:Indoles; D001761:Bleomycin; D003609:Dactinomycin; D014747:Vinblastine; D000077526:Tropisetron; D003520:Cyclophosphamide; D002945:Cisplatin